Literature DB >> 21192259

Balamuthia mandrillaris infection of the skin and central nervous system: an emerging disease of concern to many specialties in medicine.

Francisco G Bravo1, Patricia J Alvarez, Eduardo Gotuzzo.   

Abstract

PURPOSE OF REVIEW: Balamuthia mandrillaris infection of the skin and central nervous system has been increasingly reported in the last decade, making this entity a genuine emerging disease. The ability of the clinician in recognizing the skin lesion early in the course of the disease may lead to a successful therapeutic intervention in an otherwise fatal disease. RECENT
FINDINGS: In the past years, advances have been made regarding knowledge about the ubiquity of the ameba in the environment, its worldwide distribution (with higher prevalence in South America), the patients at risk (particularly those of Hispanic origin), the diagnostic methods (including those based on molecular biology) and the different therapeutic strategies that have resulted in survival of patients. A recent report dealing with organ transplant transmission of this infection has made it a subject of interest in transplant medicine.
SUMMARY: The present review will allow readers from different fields (clinician, dermatologist, neurologist, infectious disease and transplant specialist) to become familiar with the clinical aspect of the disease, including diagnosis and therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21192259     DOI: 10.1097/QCO.0b013e3283428d1e

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  11 in total

1.  Disseminated Balamuthia mandrillaris Infection.

Authors:  Katherine R Schafer; Neil Shah; M I Almira-Suarez; Jennifer M Reese; George M Hoke; James W Mandell; Sharon L Roy; Govinda Visvesvara
Journal:  J Clin Microbiol       Date:  2015-07-01       Impact factor: 5.948

2.  Transmission of Balamuthia mandrillaris through solid organ transplantation: utility of organ recipient serology to guide clinical management.

Authors:  A A Gupte; S N Hocevar; A S Lea; R D Kulkarni; D C Schain; M J Casey; I R Zendejas-Ruiz; W K Chung; C Mbaeyi; S L Roy; G S Visvesvara; A J da Silva; J Tallaj; D Eckhoff; J W Baddley
Journal:  Am J Transplant       Date:  2014-05-19       Impact factor: 8.086

Review 3.  Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.

Authors:  Kathleen E Sullivan; Hamid Bassiri; Ahmed A Bousfiha; Beatriz T Costa-Carvalho; Alexandra F Freeman; David Hagin; Yu L Lau; Michail S Lionakis; Ileana Moreira; Jorge A Pinto; M Isabel de Moraes-Pinto; Amit Rawat; Shereen M Reda; Saul Oswaldo Lugo Reyes; Mikko Seppänen; Mimi L K Tang
Journal:  J Clin Immunol       Date:  2017-08-07       Impact factor: 8.317

Review 4.  Various brain-eating amoebae: the protozoa, the pathogenesis, and the disease.

Authors:  Hongze Zhang; Xunjia Cheng
Journal:  Front Med       Date:  2021-11-26       Impact factor: 4.592

5.  Assessment of blood-brain barrier penetration of miltefosine used to treat a fatal case of granulomatous amebic encephalitis possibly caused by an unusual Balamuthia mandrillaris strain.

Authors:  Sharon L Roy; Jane T Atkins; Rosemaria Gennuso; Danny Kofos; Rama R Sriram; Thomas P C Dorlo; Teresa Hayes; Yvonne Qvarnstrom; Zuzana Kucerova; B Joseph Guglielmo; Govinda S Visvesvara
Journal:  Parasitol Res       Date:  2015-09-02       Impact factor: 2.289

6.  Encephalitis caused by pathogens transmitted through organ transplants, United States, 2002-2013.

Authors:  Sridhar V Basavaraju; Matthew J Kuehnert; Sherif R Zaki; James J Sejvar
Journal:  Emerg Infect Dis       Date:  2014-09       Impact factor: 6.883

Review 7.  Fatal Balamuthia amebic encephalitis in a healthy child: a case report with review of survival cases.

Authors:  A Krasaelap; S Prechawit; J Chansaenroj; P Punyahotra; T Puthanakit; K Chomtho; S Shuangshoti; J Amornfa; Y Poovorawan
Journal:  Korean J Parasitol       Date:  2013-06-30       Impact factor: 1.341

8.  Functional Assessment of 2,177 U.S. and International Drugs Identifies the Quinoline Nitroxoline as a Potent Amoebicidal Agent against the Pathogen Balamuthia mandrillaris.

Authors:  Matthew T Laurie; Corin V White; Hanna Retallack; Wesley Wu; Matthew S Moser; Judy A Sakanari; Kenny Ang; Christopher Wilson; Michelle R Arkin; Joseph L DeRisi
Journal:  mBio       Date:  2018-10-30       Impact factor: 7.867

9.  Balamuthia mandrillaris infection in China: a retrospective report of 28 cases.

Authors:  Lei Wang; Wenjing Cheng; Bing Li; Zhe Jian; Xianlong Qi; Dongjie Sun; Jian Gao; Xuetao Lu; Yi Yang; Kun Lin; Chuanlong Lu; Jiaxi Chen; Chunying Li; Gang Wang; Tianwen Gao
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

10.  Cutaneous balamuthiasis: A clinicopathological study.

Authors:  Patricia Alvarez; Carlos Torres-Cabala; Eduardo Gotuzzo; Francisco Bravo
Journal:  JAAD Int       Date:  2022-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.